Blog

Richard Scolyer: Still no recurrence of my supposedly incurable glioblastoma!

Photo taken from Richard Scolyer/X

Jan 27, 2024, 07:20

Richard Scolyer: Still no recurrence of my supposedly incurable glioblastoma!

Richard Scolyer, CoMedical Director at Melanoma Institute Australia and Surgical Pathologist at Royal Prince Alfred Hospital, shared a post on X/Twitter:

“Brilliant news! Still no recurrence of my supposedly incurable glioblastoma! The median time to recurrence for all patients is 6 months. I’m now out to 8 months! Perhaps neoadjuvant/adjuvant combination immunotherapy is effective? Need clinical trial. Thanks family, Georgina Long and diverse whole team!”

Source: Richard Scolyer/X

adjuvant combination immunotherapy cancer Georgina Long glioblastoma Headlines Melanoma Institute Australia neoadjuvant immunotherapy OncoDaily Oncology Richard Scolyer Royal Prince Alfred Hospital

HYPO-RT-PC Phase III trial: Two-Week Radiotherapy Proven as Safe and Effective as Eight-Week Course for Prostate Cancer, After 10-Year Follow-Up

TOPGEAR trial at ESTRO 2025: Preoperative Chemoradiotherapy for Resectable Gastric Cancer

NIVOPOSTOP (GORTEC 2018-01): A Phase III Trial of Adjuvant Nivolumab in High-Risk Resected Head and Neck Squamous Cell Carcinoma

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Bianca Balti: The Supermodel’s Brave Battle with Ovarian Cancer